Novartis AG ADR (NVS)vsRetractable Technologies Inc (RVP)
NVS
Novartis AG ADR
$147.85
+3.44%
HEALTHCARE · Cap: $282.11B
RVP
Retractable Technologies Inc
$0.62
-0.45%
HEALTHCARE · Cap: $19.43M
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 147754% more annual revenue ($56.58B vs $38.27M). NVS leads profitability with a 23.9% profit margin vs -32.8%. NVS earns a higher WallStSmart Score of 51/100 (C-).
NVS
Buy51
out of 100
Grade: C-
RVP
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-52.5%
Fair Value
$109.60
Current Price
$147.85
$38.25 premium
Margin of Safety
+87.8%
Fair Value
$5.48
Current Price
$0.62
$4.86 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 30.5%
Keeps 24 of every $100 in revenue as profit
Generating 2.9B in free cash flow
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Grey zone — moderate risk
Revenue declined 0.7%
Earnings declined 9.3%
4.0% revenue growth
Smaller company, higher risk/reward
ROE of -15.6% — below average capital efficiency
Earnings declined 66.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.
Bull Case : RVP
The strongest argument for RVP centers on Price/Book.
Bear Case : NVS
The primary concerns for NVS are PEG Ratio, Altman Z-Score, Revenue Growth.
Bear Case : RVP
The primary concerns for RVP are Revenue Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
NVS profiles as a declining stock while RVP is a turnaround play — different risk/reward profiles.
RVP carries more volatility with a beta of 1.26 — expect wider price swings.
RVP is growing revenue faster at 4.0% — sustainability is the question.
NVS generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
NVS scores higher overall (51/100 vs 31/100), backed by strong 23.9% margins. RVP offers better value entry with a 87.8% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Retractable Technologies Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, the rest of North and South America, and internationally. The company is headquartered in Little Elm, Texas.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?